This objective requires that you implement clinical decision support (CDS) notifications in the EHR to improve health outcomes. There are two components to this objective:
Measure 1: Implement five clinical decision support interventions related to four or more clinical quality measures at a relevant point in patient care for the entire EHR reporting period.
Measure 2: The provider has enabled and implemented the functionality for drug-drug and drug-allergy interaction checks for the entire EHR reporting period.
Exclusion (learn more)
For measure 2: Any provider who writes fewer than 100 medication orders during the EHR reporting period.
The Meaningful Use Dashboard will record that this measure has been met if you have at least 5 clinical decision support (CDS) rules and at least one level of drug-drug/drug-allergy interaction checks are enabled for the entire reporting period. If you or your practice administrator change the number of CDS advisories or drug-drug/drug-allergy notification alerts to fewer than the minimum 5 required for Meaningful Use and leaves these settings for an overnight period, the Dashboard will indicate that you have not met this measure and you will not be able to re-activate this measure until the next reporting period.
It is a good practice to ensure that everyone on your staff, including EHR account administrators, understands these limitations and does not disable CDS advisories or drug-drug/drug-allergy notification alerts without understanding the ramifications to your Meaningful Use status.
Practice Fusion workflow
The requirement asks you to have 5 CDS interventions enabled for your entire reporting period. Completing the action recommended by the intervention does not impact your achievement of the measure. If you complete the action for a particular CDS intervention, the alert should not display on the Finalization screen for the next visit.
Practice Fusion currently offers several CDS advisories for providers to choose from when implementing this measure, all of which are enabled by default in your EHR account. Note: The Paroxysmal Nocturnal Hemoglobinuria (PNH) Compliance and Vaccination Compliance alerts do not count towards this measure.
If you would like to disable any of the CDS advisories or drug-drug/drug-allergy notification alerts, go to the Settings section and select CDS and Connected Care.
Ensure at least 5 CDS rules are enabled and at least one alert for drug-drug and drug-allergy interactions are enabled for the entire reporting period.
Which CDS rules does Practice Fusion support?
Practice Fusion currently supports many CDS alerts that can be used to satisfy this objective. Seven of our CDS advisories relate to Clinical Quality Measures (CQMs) that are supported by Practice Fusion. These alerts are listed below with the associated Practice Fusion-supported CQM:
Controlling High Blood Pressure (CMS 165, NQF 18))
Documentation of Current Allergies
Diabetes: Eye Exam (CMS 131, NQF 55)
Diabetes: Foot Exam (CMS 123, NQF 56)
Diabetes: Hemoglobin A1c Poor Control (CMS 122, NQF 59)
Documentation of Current Medications in the Medical Record (CMS 68, NQF 419)
Screening for Clinical Depression and Follow-Up Plan (CMS 2, NQF 418)
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up (CMS 69, NQF 0421)
Below are some of our additional CDS advisories that relate to CQMs that are not currently supported by Practice Fusion:
COPD Management (3 separate alerts)
Asthma Management (3 separate alerts)
Urinary incontinence (3 separate alerts)
For more information on the CQMs that these CDS advisories pertain to, click the Reference Information link found within the CDS notification.
Review the CMS specifications for more information about this measure.
For more information on the EHR Incentive program, you should visit the Meaningful Use Center.